Arete Wealth Advisors »

Fate Therapeutics shares owned by Arete Wealth Advisors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Arete Wealth Advisors from 13F filings

Historical chart of Arete Wealth Advisors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Arete Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Arete Wealth Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $405k 150k 2.70

More positions owned by Arete Wealth Advisors

Apple Equity (AAPL)
Invesco Exchange Traded Etf (RSP)
Blackrock Etf Trust Ii Etf (BINC)
Disney Walt Equity (DIS)
Nvidia Corporation Equity (NVDA)
Fidelity Merrimack Str Tr Etf (FBND)
Putnam Etf Trust Etf (PVAL)
Spdr Series Trust Etf (SPAB)
Spdr Series Trust Etf (SPYM)
Vanguard Index Fds Etf (VUG)
Ishares Tr Etf (EFV)
Amazon Equity (AMZN)
Microsoft Corp Equity (MSFT)
Alphabet Equity (GOOGL)
Spdr Series Trust Etf (BIL)

View all positions for Arete Wealth Advisors

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Acadian Asset Management
AQR Capital Management
Two Sigma Investments
Johnson & Johnson
Renaissance Technologies
Millennium Management
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Jane Street
Citadel Advisors

View all funds holding Fate Therapeutics